ClinConnect ClinConnect Logo
Search / Trial NCT06731257

Virtual Ward-Assisted Very earLy dIschArge of Low-rIsk STEMI patieNTs: the VALIANT-STEMI Trial

Launched by THE LEEDS TEACHING HOSPITALS NHS TRUST · Dec 11, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

The VALIANT-STEMI Trial is studying whether it is safe for low-risk patients who have had a heart attack (specifically, a type called ST elevation myocardial infarction or STEMI) to go home from the hospital just 24 hours after treatment, with follow-up care provided through phone calls. The goal is to see if this early discharge can help patients feel better and reduce the time they spend in the hospital, which could also save costs for the healthcare system. Researchers will compare two groups: one that receives standard care and one that is sent home early with virtual follow-up.

To be eligible for the trial, patients must have had successful heart treatment and meet certain health criteria, such as having a Zwolle score of 3 or lower, which helps identify them as low risk. However, those who have serious heart issues or need extra support at home will not be included. Participants can expect to receive care and guidance through phone calls after leaving the hospital, and the main focus will be on whether they need to return to the hospital or experience any serious health problems within 30 days. This trial could provide important information that helps improve how heart attack patients are cared for after treatment.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Successful revascularisation following STEMI
  • Zwolle score \<=3
  • No bystander disease awaiting inpatient intervention at the time of screening or consent (so if they have had intervention to a bystander vessel before this they would be eligible)
  • Exclusion Criteria:
  • Haemodynamic instability (Killip class \>I)
  • Left ventricular ejection fraction \<45%\<40%
  • Sustained ventricular or atrial arrhythmias requiring intervention
  • No support at home or social or physical circumstances preventing early discharge
  • Unable to use home monitoring equipment
  • Unwilling to consent or follow instructions
  • Patients visiting from out of our catchment area
  • Out-of hospital cardiac arrest
  • Patients repatriated to their local hospital within 24 hours
  • New or worsening renal failure (i.e. creatinine \>=1.5x baseline)

About The Leeds Teaching Hospitals Nhs Trust

The Leeds Teaching Hospitals NHS Trust is a prominent healthcare organization in the United Kingdom, renowned for its commitment to delivering high-quality patient care, innovative research, and advanced medical education. As a leading clinical trial sponsor, the Trust plays a pivotal role in facilitating cutting-edge research initiatives that aim to improve health outcomes and advance medical knowledge. With a multidisciplinary team of experts and access to state-of-the-art facilities, the Trust is dedicated to fostering collaboration and ensuring the highest ethical standards in clinical research, ultimately contributing to the development of new treatments and therapies for diverse patient populations.

Locations

Leeds, , United Kingdom

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported